• Careers
  • ZOLL Patient Management Network Login
  • zoll-life-vest

    Peace of mind and lifesaving therapy1,2

    LifeVest is a wearable cardioverter defibrillator (WCD) that has been worn globally by more than one million patients at risk of sudden cardiac death (SCD).3

    ZOLL LifeVest patients walks through a park with grandchild
    Woman and man in a pottery class while wearing LifeVest

    Information for patients

    What is LifeVest?

    LifeVest is a wearable cardioverter defibrillator (WCD) that has been worn globally by more than one million patients at risk of sudden cardiac death (SCD).3

    While some defibrillator devices are implanted, LifeVest is worn directly against your skin, under regular clothing. Most patients wear LifeVest until their condition improves or their doctor makes a decision about long-term care.

     When worn as directed, LifeVest can provide a constant safeguard against SCD.1,2,4

    Patient education video

    This video is for patients who have been prescribed the LifeVest WCD as well as their families and loved ones. It will tell you how LifeVest works and provide information about assembling, wearing, and caring for the LifeVest WCD.

    Patient brochure

    Getting back to life with LifeVest

    More than one million patients have worn the LifeVest® wearable cardioverter defibrillator (WCD).1 We’re here to support your recovery.

    Grandpa and child walking
    Female physicians reviewing a document in a hospital

    Information for medical professionals

    For more information about LifeVest, please visit our international English language website.

    Woman talking on the phone

    Supporting you every step of the way.

    We’re here to help. Anytime. Call for 24/7 phone support +972-372-19611 or email LifeVest.israel@zoll.com.

    1. Chung MK, Szymkiewicz SJ, Shao M, et al. Aggregate national experience with the wearable cardioverter-defibrillator: Event rates, compliance, and survival. J Am Coll Cardiol. 2010;56(3):194–203.
    2. Epstein AE, Abraham WT, Bianco NR, et al. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post myocardial infarction. J Am Coll Cardiol. 2013;62(21):2000–2007early post-myocardial infarction. J Am Coll Cardiol. 2013 Nov 19;62(21):2000-7.
    3. Based on commercial data as of November 2022.
    4. Kutyifa V, Moss AJ, Klein H, et al. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: Data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II Registry). Circulation 2015;132(17):1613-1619.